Health Care — Alle selskaper

Kurs$24.20

Omsetning$193,1 mill.

Driftsresultat—

The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.19, indicating a strong equity position relative to its liabilities. Its liquidity position is characterized…

6955TWSE—

Bonraybio Co Ltd

Driftsresultat$11,5 mill.

FCF$15,5 mill.

Bonraybio maintains a strong liquidity position, with a current ratio of 8.87, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt score…

Driftsresultat-$65,2 mill.

6973TPEx—

6973.Two

FCF-$85,0 mill.

The company maintains a strong liquidity position, with cash and equivalents amounting to TWD 404.97 million, significantly exceeding its total liabilities of TWD 52.42 million, resulting in a curr…

7759TPEx—

7759.Two

Driftsresultat-$176,3 mill.

FCF-$167,1 mill.

The company maintains a strong liquidity position, with a current ratio of 16.48, indicating a significant ability to meet short-term obligations. The company's liquidity is further supported by a…

7776Tokyo Stock Exchange—

7776.T

Driftsresultat-¥1,10 mrd.

Takeda's capital structure is characterized by a low debt-to-equity ratio of 0.1, indicating a conservative leverage position relative to its equity base. The company maintains a strong liquidity p…

7779Tokyo Stock Exchange—

Cyberdyne Inc

Driftsresultat-¥609,0 mill.

FCF-¥339,0 mill.

Cyberdyne Inc's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage profile. The company holds significant liquidity with JPY 6.824 billion…

7902TPEx—

7902.Two

The company maintains a strong liquidity position, with cash and equivalents amounting to 60,237,000 TWD, significantly exceeding its long-term debt of 2,563,000 TWD. The debt-to-equity ratio of 0.…

8143HKEX—

8143.Hk

KursHK$0.07

Driftsresultat-HK$7,2 mill.

OmsetningHK$16,1 mill.

FCFHK$1,6 mill.

The company's capital structure is characterized by a negative total equity of -6,509,000 HKD and a debt-to-equity ratio of -1.62, indicating a significant reliance on debt financing. Despite a neg…

8622HKEX—

8622.Hk

KursHK$0.21

Driftsresultat-HK$4,8 mill.

OmsetningHK$28,3 mill.

The company's capital structure shows a debt-to-equity ratio of 0.1, indicating a relatively low level of leverage. However, the company has a negative net income of -5,006,000 CNY and an operating…

9594Tadawul—

9594.Se

Kurs$5.40

Driftsresultat$22,0 mill.

Omsetning$121,8 mill.

FCF$3,0 mill.

The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.37, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medi…

9647Tadawul—

9647.Se

The company maintains a strong capital structure with no debt, as evidenced by a debt-to-equity ratio of 0.0. This indicates a conservative approach to financing, with total equity of 31,523,540.0.…

Driftsresultat-$18,4 mill.

ADPHNSE (India)—

Aarey Drugs and Pharmaceuticals Ltd

Aarey Drugs and Pharmaceuticals Ltd has a debt-to-equity ratio of 0.24, indicating a relatively conservative capital structure with limited leverage. However, the company's liquidity position is as…

ADXNNASDAQ—

Adxn.O

Pharmaceuticals

Kurs$5.00

Børsverdi$739,2 mill.

P/E—

Omsetning—

Driftsresultat—

FCF—

Dilution: Low · Liquidity: Unknown

AMES—

Ames.Ca

Kurs$54.34

Driftsresultat$68,6 mill.

Omsetning$467,9 mill.

FCF$48,4 mill.

AMES.CA maintains a strong liquidity position, with a current ratio of 1.55 and $41.1 million in cash and equivalents, indicating the company can easily cover its short-term obligations. The compan…

Driftsresultat$549,5 mill.

ANUHNSE (India)—

Anuh.Ns

FCF$234,2 mill.

ANUH.NS maintains a strong liquidity position, with a current ratio of 2.11, indicating the company can cover its short-term liabilities more than twice over with its current assets. The company's…

ANWGNXetra—

DocCheck AG

Driftsresultat€8,2 mill.

FCF€608,6k

ANWGN.DE maintains a strong liquidity position, with a current ratio of 3.18, indicating the company can easily cover its short-term liabilities with its short-term assets. The company holds EUR 14…

Driftsresultat-C$1,5 mill.

ARCHTSX Venture—

Arch Biopartners Inc.

The company's capital structure is highly leveraged, with total liabilities of CAD 3.99 billion and total equity of CAD -3.88 billion, resulting in a negative debt-to-equity ratio of -0.73. Liquidi…

Driftsresultat$210,6 mill.

ASTDBSE (India)—

Astd.Bo

Omsetning$975,1 mill.

FCF$44,9 mill.

The company's capital structure is characterized by a high debt-to-equity ratio of 2.9, indicating a significant reliance on debt financing relative to equity. Liquidity is assessed as medium, with…

ATCK.KW—

Advanced Technology Co KSCP

Driftsresultat$2,2 mill.

FCF-$9,3k

The company’s capital structure is highly leveraged, with a debt-to-equity ratio of 2.77, indicating significant reliance on debt financing. Despite holding KWD 7.34 million in cash and equivalents…

Driftsresultat$100,5 mill.

AXPH—

Alexandria Company for Pharmaceuticals and Chemical Industries SAE

Omsetning$460,9 mill.

FCF$35,0 mill.

Alexandria Company for Pharmaceuticals and Chemical Industries SAE maintains a strong liquidity position, with a current ratio of 1.92, indicating that it has sufficient current assets to cover its…

Driftsresultat$576,1 mill.

BAJHNSE (India)—

Bajh.Ns

FCF$565,5 mill.

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.48, below the industry median of 0.65, indicating a lower reliance on debt financing. Free cash flow of INR 5…

BAX.HN—

Thong Nhat JSC

Driftsresultat$11,06 mrd.

FCF$3,72 mrd.

Thong Nhat JSC maintains a strong liquidity position, with a current ratio of 7.43, indicating a significant buffer of current assets over current liabilities. The company's cash and equivalents am…

Driftsresultat-€1,08 mrd.

BAYGNXetra—

Baygn.De

FCF-€2,15 mrd.

BAYGN.DE operates in the Pharmaceuticals industry within the Health Care sector, generating revenue through pharmaceutical products and research activities. The company is classified under the Phar…

BNTXNASDAQ—

Biontech SE

CBLASX—

Cbl.Ax

Driftsresultat-A$5,9 mill.

FCF-A$5,6 mill.

CBL.AX exhibits a capital structure with a low debt-to-equity ratio of 0.08, indicating a conservative leverage profile. However, the company's liquidity position is rated as medium, with a current…

Healthcare Providers & Services

CDIX.PKOTC—

Cardiff Lexington Corporation

Driftsresultat$1,1 mill.

FCF-$6,8 mill.

CDIX has a capital structure marked by a high debt-to-equity ratio of 6.08, indicating a significant reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio…

COEGIN—

Coegin Pharma AB

Driftsresultat-$20,5 mill.

FCF-$17,6 mill.

COEGIN.NGM maintains a strong liquidity position, with cash and equivalents amounting to 7,923,000 SEK, which exceeds its total liabilities of 8,599,000 SEK. The company's current ratio of 1.16 ind…

CUEASX—

Cue.Ax

KursA$0.13

DriftsresultatA$19,7 mill.

OmsetningA$54,8 mill.

FCF-A$14,1 mill.

CUE.AX maintains a strong liquidity position, with a current ratio of 2.53, indicating the company can cover its short-term liabilities more than twice over with its current assets. The company's l…

DADI—

Dar Al Dawa Development and Investment Company PSC

Driftsresultat$1,3 mill.

FCF$532,6k

Dar Al Dawa has a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing, and a current ratio of 1.22, suggesting limited short-term liquidity cushion. The company's negativ…

Driftsresultat$35,38 mrd.

DCL—

Cuu Long Pharmaceutical JSC

Omsetning$277,94 mrd.

FCF-$43,96 mrd.

Cuu Long Pharmaceutical JSC maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.48, indicating a moderate reliance on debt financing. However, the company's liqu…

DGQ.ASE—

Delta Gold Technologies PLC

Delta Gold Technologies PLC has a fully diluted share count of 64,644,364 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or conve…

DTR.CD—

DiagnosTear Technologies Inc.

Driftsresultat-$3,6 mill.

FCF-$3,2 mill.

DTR.CD's capital structure is characterized by a low debt-to-equity ratio of 0.07, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a current ratio o…

Driftsresultat$50,15 mrd.

DVM.HN—

Dvm.Hn

FCF$64,72 mrd.

DVM.HN maintains a capital structure with a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a curre…

EARKBSE (India)—

Eark.Bo

Kurs$148.75

Driftsresultat$186,8 mill.

Omsetning$431,1 mill.

FCF$136,6 mill.

EARK.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as…

ECORBursa Malaysia—

Ecor.Kl

Kurs$0.25

Omsetning$110,9 mill.

Driftsresultat$9,7 mill.

FCF-$6,1 mill.

ECOR.KL has a liquidity position that is characterized by a current ratio of 2.61, indicating that the company has sufficient current assets to cover its current liabilities more than twice over. H…

EDX.ASE—

Edx Medical Group PLC

Driftsresultat-$4,3 mill.

FCF-$3,5 mill.

EDX.ASE exhibits a strong liquidity position, with a current ratio of 3.32, indicating the company can cover its short-term liabilities more than three times over. The company holds GBP 2,402,630 i…

EPITTASE (Tel Aviv)—

Epit.Ta

Driftsresultat-$9,5 mill.

FCF-$9,4 mill.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.21, indicating a conservative leverage position. It maintains a strong liquidity position with a current ratio of…

Biotechnology & Life-Science Tools

EXOZNASDAQ—

eXoZymes Inc

Driftsresultat-$9,7 mill.

FCF-$9,0 mill.

eXoZymes Inc maintains a strong liquidity position, with $3.04 million in cash and equivalents, representing 50.9% of total assets. The company's price-to-book ratio of 25.01 indicates a high valua…

FREASX—

Fre.Ax

KursA$0.04

BørsverdiA$11,1 mill.

Driftsresultat-A$2,9 mill.

OmsetningA$293,4k

FCF-A$2,7 mill.

FRE.AX has a market price of 0.04 AUD and a market capitalization of 11,390,159.4 AUD, indicating a small-cap profile. The company's price-to-book ratio is 7.32, and its price-to-tangible-book rati…

GRTX.PKOTC—

Grtx.Pk

Driftsresultat$148,5 mill.

FCF$149,0 mill.

GRTX.PK maintains a strong liquidity position with a current ratio of 11.0, indicating a significant buffer of current assets over current liabilities. The company's cash and equivalents amount to…

HEMTSX Venture—

Hem.V

KursC$0.06

BørsverdiC$10,9 mill.

HEM.V's capital structure is characterized by a negative equity position of $4.97 million and a debt-to-equity ratio of -0.72, indicating a significant reliance on debt financing. The company's liq…

IGCLondon Stock Exchange—

India Capital Growth Fund Ltd

Biotechnology & Life-Science Tools

India Capital Growth Fund Ltd operates with a capital structure that is not fully disclosed, as liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern…

Diversified Pharmaceuticals

INIS.PKOTC—

Radnostix, Inc.

Driftsresultat-$266,2k

FCF-$223,5k

RADNOSTIX, INC. has a liquidity position that is below the typical threshold for financial stability, with a current ratio of 0.7. The company's cash and equivalents amount to $2,368,500, while its…

JSPMSET (Bangkok)—

JSP Pharmaceutical Manufacturing (Thailand) PCL

Omsetning$155,7 mill.

Driftsresultat$545,0k

FCF-$5,2 mill.

JSP Pharmaceutical Manufacturing (Thailand) PCL has a debt-to-equity ratio of 0.35, indicating a relatively conservative capital structure with a moderate reliance on debt financing. However, the c…

Diversified Pharmaceuticals

KPTIBSE (India)—

KPT Industries Ltd

Kurs$476.20

Driftsresultat$54,3 mill.

Omsetning$391,9 mill.

KPT Industries Ltd maintains a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium risk, w…

LIXTNASDAQ—

Lixte Biotechnology Holdings Inc

Driftsresultat-$966,9k

Lixte Biotechnology has a market capitalization of $58.55 million and a price-to-book ratio of 18.73, indicating a premium valuation relative to its book value. The company has no long-term debt an…

LOTSNSE (India)—

Lotus Eye Hospital and Institute Ltd

Kurs$106.56

Driftsresultat-$3,6 mill.

Omsetning$108,8 mill.

Lotus Eye Hospital and Institute Ltd maintains a strong liquidity position, with a current ratio of 2.25 and cash and equivalents of INR 25.82 million. The company's debt-to-equity ratio is 0.02, i…

LUCDNASDAQ—

Lucid Diagnostics Inc

Kurs$0.97

Børsverdi$127,2 mill.

Driftsresultat-$49,6 mill.

Omsetning$4,7 mill.

FCF-$46,7 mill.

Lucid Diagnostics Inc operates in the Health Care Equipment & Supplies industry, generating revenue through diagnostic services and products. The company is classified under the Health Care sector…

MPOS.TE—

Micropos Medical AB (publ)

Driftsresultat-$21,6 mill.

FCF-$22,5 mill.

MPOS.TE exhibits a capital structure with no debt, as evidenced by a debt-to-equity ratio of 0.0, and a strong current ratio of 3.26, indicating robust short-term liquidity. However, the company re…

MRKXetra—

Mrk.De

Driftsresultat€21,22 mrd.

Kurs€143.70

Børsverdi€354,91 mrd.

P/E39,2

Omsetning€65,01 mrd.

FCF€11,82 mrd.

MRK.DE operates in the pharmaceuticals industry, generating revenue through the development and sale of pharmaceutical products. The company is classified within the Pharmaceuticals industry under…

MTNPWarsaw Stock Exchange—

Milton Essex SA

Milton Essex SA has a fully diluted share count of 15,517,670 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible…

Driftsresultat$619,1 mill.

NBIXNASDAQ—

Neurocrine Biosciences, Inc

FCF$748,7 mill.

Neurocrine Biosciences, Inc. is a biotechnology company that develops and commercializes pharmaceutical products, generating revenue through the sale of its approved therapies and ongoing research…

Driftsresultat-$2,6 mill.

NCELNASDAQ—

Ncel.O

FCF-$2,8 mill.

NCEL.O is a biotechnology company operating within the Health Care sector, though specific product details and revenue sources are not disclosed in the available data. The company is classified und…

NINH—

Ninh.Ca

Kurs$19.11

Driftsresultat$136,9 mill.

Omsetning$525,5 mill.

FCF$121,2 mill.

NINH.CA maintains a strong liquidity position, with a current ratio of 5.69, indicating a robust ability to meet short-term obligations. The company's cash and equivalents amount to $113.6 million,…

NNGWarsaw Stock Exchange—

Nanogroup SA

Driftsresultat-$1,3 mill.

FCF-$1,6 mill.

Nanogroup SA has a capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a fully equity-financed operation. The company holds cash and equivalents of PLN 1,079,000,…

NTIASX—

Neurotech International Ltd

Driftsresultat-A$10,6 mill.

FCF-A$10,6 mill.

Neurotech International operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0. The company's liquidity position is strong, with a current r…

Driftsresultat$452,8 mill.

NVAXNASDAQ—

Nvax.O

ONCSMBorsa Istanbul—

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS

Kurs$325.00

Driftsresultat$19,0 mill.

Omsetning$111,3 mill.

FCF-$16,9 mill.

Oncosem maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.34, indicating a moderate reliance on debt financing. The company holds 34,988,630 TRY in cash and eq…

POXELEuronext Paris—

Poxel.Pa

POXEL's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no going-concern language in source documents, preventing a liquidity risk assessment.…

PRME.CD—

Prime Drink Group Corp

Prime Drink Group Corp has a fully diluted share count of 372,970,512, with no additional shares outstanding in the diluted scenario, indicating no immediate dilution risk from stock options or con…

SEYKMBorsa Istanbul—

Seykm.Is

Kurs$5.44

Børsverdi$1,09 mrd.

Driftsresultat-$22,6 mill.

Omsetning$242,2 mill.

FCF-$32,3 mill.

The company's capital structure is characterized by a high proportion of equity, with total equity of 495,021,010 TRY and total liabilities of 86,599,260 TRY, resulting in a debt-to-equity ratio of…

SHRXTSX Venture—

Sharp Therapeutics Corp

Driftsresultat-C$21,1k

FCF-C$21,1k

Sharp Therapeutics Corp has a highly liquid balance sheet, with a current ratio of 11.6, indicating strong short-term liquidity. The company has no long-term debt and a debt-to-equity ratio of 0.0,…

Driftsresultat$722,01 mrd.

SOHOIDX (Jakarta)—

Soho Global Health Tbk PT

Omsetning$10,78 bill.

FCF$312,75 mrd.

Soho Global Health Tbk PT maintains a strong liquidity position, with a current ratio of 1.63, indicating the company can cover its short-term liabilities with its short-term assets. The company's…

STAAIDX (Jakarta)—

Sumber Tani Agung Resources Tbk PT

Driftsresultat$2,37 bill.

FCF$1,04 bill.

Sumber Tani Agung Resources Tbk PT maintains a strong liquidity position, with a current ratio of 3.18, indicating the company can cover its short-term liabilities more than three times over. The c…

THQM.BB—

Tchaikapharma High Quality Medicines AD

Driftsresultat$1,8 mill.

FCF$2,1 mill.

Tchaikapharma High Quality Medicines AD maintains a conservative capital structure, with a debt-to-equity ratio of 0.1, indicating minimal reliance on debt financing. The company's liquidity positi…

TRDANASDAQ—

Entrada Therapeutics Inc

Biotechnology

Kurs$7.26

Børsverdi$277,9 mill.

Driftsresultat-$157,9 mill.

Omsetning$25,4 mill.

FCF-$129,6 mill.

Entrada Therapeutics Inc is a biotechnology company operating in the Health Care sector, developing therapeutic solutions within the biotechnology industry. The company is classified under the Biot…

WPHSET (Bangkok)—

Wph.Bk

Driftsresultat$459,5 mill.

FCF-$337,3 mill.

WPH.BK has a market price of 5.95 THB, with a market capitalization of 4,249,052,454.85 THB, indicating a moderate valuation. The company's price-to-earnings ratio is 12.08, and its price-to-book r…

0007J0KOSDAQ—

0007j0.Kq

Driftsresultat-$6,37 mrd.

FCF-$5,78 mrd.

The company maintains a strong liquidity position, with a current ratio of 93.84, indicating that it holds significantly more current assets than current liabilities. However, it is experiencing ne…

Driftsresultat₩251,6 mill.

002620KRX—

Jeil Pharma Holdings Inc

Omsetning₩188,83 mrd.

FCF-₩309,8 mill.

Jeil Pharma's capital structure is characterized by a debt-to-equity ratio of 0.49, indicating a relatively balanced mix of debt and equity financing. The company's liquidity position is assessed a…

003060KRX—

003060.Ks

The company's capital structure is characterized by a debt-to-equity ratio of 0.8, indicating a moderate reliance on debt financing relative to equity. Despite holding KRW 24,392,535,690 in cash an…

Driftsresultat₩23,44 mrd.

009290KRX—

009290.Ks

FCF₩8,51 mrd.

The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.46, indicating a moderate reliance on debt financing. However, the company's liquidity position is as…

Driftsresultat-₩941,3 mill.

017180KRX—

Myungmoon Pharm Co Ltd

FCF-₩718,4 mill.

Myungmoon Pharm Co Ltd has a debt-to-equity ratio of 1.08, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is weak, with a current ratio of 0.6…

104540KOSDAQ—

Corentec Co Ltd

Driftsresultat$22,5 mill.

FCF-$2,74 mrd.

Corentec Co Ltd has a liquidity position that is currently medium, with a current ratio of 1.24 and a debt-to-equity ratio of 0.66. The company's price-to-book ratio is 0.85, indicating that the ma…

115480KOSDAQ—

115480.Kq

Driftsresultat$10,81 mrd.

FCF$2,94 mrd.

The company maintains a relatively strong liquidity position, with a current ratio of 4.84, indicating that it has sufficient current assets to cover its current liabilities. However, its liquidity…

131220KOSDAQ—

131220.Kq

Driftsresultat$5,53 mrd.

FCF$5,57 mrd.

The company maintains a strong liquidity position, with a current ratio of 3.68, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to 4,924,425,230 KRW, an…

Driftsresultat-HK$14,0 mill.

1643HKEX—

Modern Chinese Medicine Group Co Ltd

OmsetningHK$145,2 mill.

Modern Chinese Medicine Group Co Ltd has a current ratio of 8.54, indicating strong short-term liquidity, but its return on equity of -2.72% and return on assets of -2.49% suggest poor profitabilit…

1799TPEx—

Easywell Biomedicals Inc

Easywell Biomedicals Inc has a fully diluted share count of 124,690,000 shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock opt…

1AIASX—

Algorae Pharmaceuticals Ltd

Algorae Pharmaceuticals Ltd has a fully diluted share count of 202,307,015.55 shares, with no additional shares outstanding in the diluted scenario, indicating no immediate dilution pressure from s…

214610KOSDAQ—

214610.Kq

Driftsresultat-$12,01 mrd.

FCF-$25,09 mrd.

The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 17,942,439,830, which significantly exceeds its total liabilities of KRW 9,420,994,410, resulting in a…

2297HKEX—

Rainmed Medical Ltd

Rainmed Medical Ltd's capital structure and liquidity position are not fully assessable due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company…

2496HKEX—

2496.Hk

KursHK$5.16

Driftsresultat-HK$79,8 mill.

OmsetningHK$66,9 mill.

FCF-HK$81,2 mill.

The company's capital structure is characterized by a negative total equity of CNY -53,029,000 and a debt-to-equity ratio of -2.41, indicating a significant reliance on debt financing and a lack of…

300246Shenzhen Stock Exchange—

Guangdong Biolight Meditech Co Ltd

Driftsresultat-$72,6 mill.

FCF-$188,0 mill.

Guangdong Biolight Meditech Co Ltd has a debt-to-equity ratio of 0.64, indicating a moderate level of leverage, and a current ratio of 1.59, suggesting it has sufficient short-term assets to cover…

334970KOSDAQ—

334970.Kq

Kurs$2065.00

Børsverdi$160,56 mrd.

Driftsresultat-$33,68 mrd.

Omsetning$12,53 mrd.

FCF-$20,04 mrd.

The company's capital structure is characterized by a debt-to-equity ratio of 0.68, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…

3689HKEX—

3689.Hk

KursHK$1.88

DriftsresultatHK$158,3 mill.

OmsetningHK$2,02 mrd.

The company maintains a relatively strong liquidity position, with a current ratio of 1.35, indicating that it has sufficient current assets to cover its current liabilities. However, the company's…

3737HKEX—

3737.Hk

DriftsresultatHK$24,4 mill.

KursHK$0.70

BørsverdiHK$604,5 mill.

P/E38,0

OmsetningHK$1,74 mrd.

FCFHK$46,4 mill.

The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.12, indicating a conservative leverage position. Its liquidity is assessed as medium, with a current r…

4155TWSE—

4155.Tw

Driftsresultat$107,9 mill.

FCF-$262,5 mill.

The company maintains a debt-to-equity ratio of 0.4, indicating a relatively conservative capital structure with a strong equity base. However, the free cash flow is negative at -262.5 million TWD,…

Driftsresultat$252,4 mill.

4166TPEx—

Orient Pharma Co Ltd

FCF$294,6 mill.

Orient Pharma Co Ltd maintains a strong liquidity position, with a current ratio of 6.73, indicating that the company has more than six times the current assets to cover its current liabilities. Th…

4591Tokyo Stock Exchange—

Ribomic Inc

Driftsresultat-¥326,8 mill.

Ribomic maintains a strong liquidity position, with cash and equivalents amounting to ¥2.1 billion, representing 59.3% of total assets. The company's liquidity FPT (free cash flow to total liabilit…

600721Shanghai Stock Exchange—

Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Driftsresultat$44,0 mill.

Kurs$7.68

Børsverdi$2,95 mrd.

P/E70,4

Omsetning$388,3 mill.

FCF$41,3 mill.

The company maintains a strong liquidity position, with a current ratio of 2.29, indicating that it has more than twice the current assets to cover its current liabilities. However, its liquidity r…

6492TPEx—

Senhwa Biosciences Inc

Driftsresultat-$311,1 mill.

FCF-$290,4 mill.

Senhwa Biosciences Inc maintains a strong liquidity position, with cash and equivalents amounting to TWD 547.46 million, representing 40.1% of total assets. The company's liquidity FPT (free cash f…

6617TPEx—

6617.Two

Driftsresultat-$207,3 mill.

FCF-$112,4 mill.

The company maintains a strong liquidity position, with a current ratio of 10.36, indicating that it has significantly more current assets than current liabilities. It holds cash and equivalents of…

6872TPEx—

NaviFUS Corp

Driftsresultat-$25,9 mill.

FCF-$43,9 mill.

NaviFUS Corp maintains a strong liquidity position with $307.2 million in cash and equivalents, representing 48.4% of total assets. The company's liquidity FPT score indicates a low liquidity risk,…

8223HKEX—

8223.Hk

KursHK$0.26

BørsverdiHK$131,6 mill.

DriftsresultatHK$6,6 mill.

OmsetningHK$513,8 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 0.85, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…

8409TPEx—

EBM Technologies Inc

Kurs$19.15

Børsverdi$612,8 mill.

Driftsresultat-$24,4 mill.

Omsetning$26,9 mill.

FCF-$19,3 mill.

EBM Technologies Inc has a market capitalization of TWD 611.2 million and a price-to-book ratio of 2.12, indicating a moderate premium to its book value. The company holds TWD 144.8 million in cash…

950130KOSDAQ—

Access Bio Inc

Driftsresultat$1,6 mill.

FCF$5,2 mill.

Access Bio Inc maintains a strong liquidity position with a current ratio of 10.11, indicating that it holds significantly more current assets than current liabilities. However, the company has a n…

9574Tadawul—

9574.Se

Kurs$85.60

Driftsresultat$59,6 mill.

Omsetning$418,8 mill.

FCF$22,6 mill.

The company maintains a debt-to-equity ratio of 0.84, indicating a moderate level of leverage, and a current ratio of 1.55, suggesting it has sufficient short-term assets to cover its short-term li…

AOXISGX—

Aoxin Q & M Dental Group Ltd

Kurs$0.26

Driftsresultat$10,7 mill.

Omsetning$171,0 mill.

FCF$19,5 mill.

Aoxin Q & M Dental Group Ltd maintains a strong liquidity position, with a current ratio of 7.82, indicating that it holds significantly more current assets than current liabilities. The company's…

ASARBSE (India)—

Asarfi Hospital Ltd

BGHYDR.BB—

Green Innovation AD

Green Innovation AD maintains a conservative capital structure, with a debt-to-equity ratio of 0.09, indicating a strong equity position relative to its liabilities. The company's liquidity is refl…

BIOPWarsaw Stock Exchange—

Bioton SA

Driftsresultat-$5,5 mill.

FCF-$1,9 mill.

Bioton's capital structure is characterized by a relatively low debt-to-equity ratio of 0.1, indicating a conservative leverage position. However, the company's liquidity is rated as medium, with a…

CCCJ.J—

Cilo Cybin Holdings Ltd

Cilo Cybin Holdings Ltd has an equal number of basic and diluted shares outstanding, with 230,475,136 shares in both categories, indicating no immediate dilution pressure from stock options or conv…

Driftsresultat$84,6 mill.

CPCI—

Kahira Pharmaceuticals and Chemical Industries Co

Omsetning$336,4 mill.

FCF$247,4 mill.

Kahira Pharmaceuticals maintains a conservative capital structure with a debt-to-equity ratio of 0.34, indicating a relatively low reliance on debt financing. The company's liquidity position is ch…

CSDX.PKOTC—

CS Diagnostics Corp

CS Diagnostics Corp has an equal number of basic and diluted shares outstanding, with 249,992,200 shares in both categories, indicating no immediate dilution pressure from stock options or converti…

CTGL.PKOTC—

SkyTech Orion Global Corp

Driftsresultat-$403,0k

FCF-$252,0k

SkyTech Orion Global Corp exhibits a highly leveraged capital structure, with total liabilities of $5.18 million and total equity of -$2.63 million, resulting in a negative debt-to-equity ratio of…

Driftsresultat-$1,5 mill.

CURN—

Curatis Holding AG

FCF-$2,3 mill.

Curatis operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company maintains a current ra…

EBMTSX Venture—

Ebm.V

Driftsresultat-C$332,8k

FCF-C$287,8k

EBM.V's capital structure is highly leveraged, with total liabilities of CAD 1.85 billion and total equity of CAD -1.63 billion, resulting in a negative debt-to-equity ratio of -0.05. The company's…

FONETBorsa Istanbul—

Fonet.Is

Kurs$5.53

Driftsresultat$282,3 mill.

Omsetning$855,1 mill.

FCF$114,2 mill.

FONET.IS maintains a strong liquidity position with a current ratio of 2.34, indicating the company can cover its short-term liabilities more than twice over. However, the company has a negative ne…

Driftsresultat$93,8 mill.

GDRUBSE (India)—

Gdru.Bo

FCF-$131,7 mill.

GDRU.BO maintains a capital structure with a debt-to-equity ratio of 1.48, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a curr…

GOHOTASE (Tel Aviv)—

Goho.Ta

Driftsresultat$14,0 mill.

FCF-$192,2 mill.

GOHO.TA maintains a strong liquidity position, with cash and equivalents amounting to ILS 81.77 million, representing 19.77% of total assets. The company's liquidity FPT (free cash flow to total as…

HBPTSX—

Helix Biopharma Corp.

Driftsresultat-C$5,4 mill.

FCF-C$5,2 mill.

HBP.TO has a weak capital structure and liquidity position, as indicated by a negative net cash position after subtracting total debt. The company's debt-to-equity ratio is 0.02, suggesting minimal…

Driftsresultat-$10,1 mill.

IXBISGX—

Ixbi.Si

FCF-$9,5 mill.

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 16.17, indicating a significant reliance on debt financing. Its liquidity position is weak, as evidenced by a cur…

MEDTRBorsa Istanbul—

Medtr.Is

Driftsresultat$94,6 mill.

FCF-$64,7 mill.

The company maintains a strong liquidity position, with a current ratio of 3.36, indicating that it holds more than three times as many current assets as current liabilities. Its cash and equivalen…

Driftsresultat$197,6 mill.

PALABSE (India)—

Pala.Bo

FCF$3,4 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 0.84, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…

PMCKBursa Malaysia—

Pmck.Kl

Driftsresultat$16,1 mill.

FCF$200,0k

PMCK.KL maintains a relatively strong liquidity position, with a current ratio of 2.84, indicating that the company has sufficient current assets to cover its current liabilities. However, the comp…

PRTANSE (India)—

Pratham EPC Projects Ltd

Pratham EPC Projects Ltd has a basic and diluted share count of 18,212,489 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. Ho…

SDSPWarsaw Stock Exchange—

SDS Optic SA

Driftsresultat-$2,5 mill.

FCF-$2,4 mill.

SDS Optic SA exhibits a weak capital structure and liquidity position, with a current ratio of 0.94, indicating that its current liabilities exceed its current assets. The company has no long-term…

STETSX Venture—

Ste.V

Driftsresultat-C$798,6k

FCF-C$967,6k

STE.V's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is weak, as evidenced by a current ratio of 0…

Driftsresultat$205,8 mill.

TECH—

Techno Drugs Ltd

Techno Drugs Ltd has a capital structure characterized by a net income of BDT 100.38 million and an operating cash flow of BDT 115.47 million, indicating positive cash generation from operations. H…

TELABursa Malaysia—

Teladan Group Bhd

Kurs$0.79

Driftsresultat$46,9 mill.

Omsetning$305,4 mill.

FCF$21,2 mill.

Teladan Group Bhd maintains a debt-to-equity ratio of 0.58, indicating a relatively conservative capital structure. The company's liquidity position is assessed as medium, with a current ratio of 4…

Driftsresultat$391,2 mill.

THEMNSE (India)—

Them.Ns

FCF$197,3 mill.

Themis Bioscience maintains a conservative capital structure with a debt-to-equity ratio of 0.21, indicating a relatively low reliance on debt financing. The company's liquidity position is charact…

Driftsresultat$341,05 mrd.

TRA—

Tra.Hm

FCF$95,33 mrd.

TRA.HM maintains a strong liquidity position with a current ratio of 2.76, indicating the company can cover its short-term liabilities more than two times over. However, the company's net cash posi…

Driftsresultat$91,0 mill.

TTKHNSE (India)—

TTK Healthcare Ltd

TTK Healthcare Ltd maintains a strong liquidity position with a current ratio of 5.35, indicating a robust ability to meet short-term obligations. The company's cash and equivalents amount to INR 7…

Driftsresultat$93,0 mill.

TYCHBSE (India)—

Tych.Bo

Omsetning$654,7 mill.

FCF$111,1 mill.

TYCH.BO maintains a strong liquidity position, with a current ratio of 12.57, indicating a significant buffer of current assets over current liabilities. The company has no long-term debt, and its…

002437Shenzhen Stock Exchange—

Harbin Gloria Pharmaceuticals Co Ltd

Driftsresultat$404,3 mill.

FCF$448,0 mill.

HARBIN GLORIA PHARMACEUTICALS Co Ltd maintains a strong capital structure with a low debt-to-equity ratio of 0.04, indicating minimal reliance on debt financing. The company's liquidity position is…

002524Shenzhen Stock Exchange—

002524.Sz

Kurs$4.22

Omsetning$885,2 mill.

Driftsresultat$4,2 mill.

FCF$22,8 mill.

The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 8.2, indicating a significant reliance on debt financing. Despite a negative net income of -19,497,360 CNY, the…

006620KOSDAQ—

DongKoo Bio & Pharma Co Ltd

Driftsresultat$4,66 mrd.

FCF-$6,91 mrd.

DongKoo Bio & Pharma maintains a debt-to-equity ratio of 0.45, indicating a relatively conservative capital structure with liabilities significantly below equity. The company's liquidity position i…

039860KOSDAQ—

NanoEnTek Inc

Driftsresultat-$83,1 mill.

Kurs$5780.00

Børsverdi$218,74 mrd.

P/E368,9

Omsetning$6,59 mrd.

FCF$905,3 mill.

NanoEnTek maintains a strong liquidity position with a current ratio of 10.2 and cash and equivalents of KRW 5,299,261,770, which significantly exceeds its short-term obligations. The company's pri…

049960KOSDAQ—

049960.Kq

Driftsresultat$7,92 mrd.

FCF$7,45 mrd.

The company maintains a strong capital structure, with a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. Its liquidity position is characterized as medium, with a current rat…

Driftsresultat-HK$156,0 mill.

1477HKEX—

Ocumension Therapeutics

OmsetningHK$804,4 mill.

Ocumension Therapeutics maintains a strong liquidity position with a current ratio of 3.7, indicating the company can cover its short-term obligations more than three times over. However, the compa…

Driftsresultat$295,3 mill.

1752TWSE—

1752.Tw

FCF-$15,7 mill.

The company maintains a relatively strong liquidity position, with a current ratio of 1.4, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liqu…

228760KOSDAQ—

228760.Kq

Kurs$12480.00

Børsverdi$299,80 mrd.

Driftsresultat-$11,31 mrd.

Omsetning$3,76 mrd.

FCF-$10,85 mrd.

The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 16,314,618,920 and a current ratio of 17.75, indicating a high ability to meet short-term obligations.…

235980KOSDAQ—

235980.Kq

Kurs$4645.00

Børsverdi$159,21 mrd.

Driftsresultat-$13,88 mrd.

Omsetning$3,90 mrd.

FCF-$11,90 mrd.

The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 11,997,347,140, which is significantly higher than its total liabilities of KRW 2,681,222,550, resultin…

2566HKEX—

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd

KursHK$6.70

BørsverdiHK$1,62 mrd.

The company's capital structure is characterized by a market capitalization of 1.49 billion CNY, with a market price of 6.16 CNY per share. The shares outstanding are 241.52 million for both basic…

2581HKEX—

BenQ BM Holding Cayman Corp

BenQ BM Holding Cayman Corp has a basic and diluted share count of 311,945,001, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to…

Driftsresultat-₩2,21 mrd.

271980KRX—

Jeil Pharmaceutical Co Ltd

Omsetning₩170,42 mrd.

FCF-₩2,51 mrd.

Jeil Pharmaceutical's capital structure shows a debt-to-equity ratio of 0.55, indicating moderate leverage relative to its equity base. The company's liquidity position is assessed as medium, with…

300030Shenzhen Stock Exchange—

Improve Medical Instruments Co Ltd

Kurs$8.15

Driftsresultat-$1,4 mill.

Omsetning$152,0 mill.

Improve Medical Instruments Co Ltd has a debt-to-equity ratio of 0.48, indicating a relatively conservative capital structure. However, the company reported negative net income of -2,084,430 and ne…

300318Shenzhen Stock Exchange—

Beijing Bohui Innovation Biotechnology Group Co Ltd

Omsetning$824,6 mill.

Driftsresultat-$127,7 mill.

FCF-$264,6 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…

300942Shenzhen Stock Exchange—

Shenzhen Bioeasy Biotechnology Co Ltd

Kurs$7.10

Børsverdi$2,88 mrd.

P/E208,4

Omsetning$263,2 mill.

Driftsresultat$5,7 mill.

FCF-$14,4 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 0.5, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current rat…

301166Shenzhen Stock Exchange—

301166.Sz

Driftsresultat$733,0k

FCF-$79,4 mill.

The company maintains a strong liquidity position, with a current ratio of 8.7, indicating a high ability to meet short-term obligations. However, its free cash flow is negative at -79,358,890 CNY,…

301617Shenzhen Stock Exchange—

Shandong Boyuan Pharmaceutical & Chemical Co Ltd

Driftsresultat$196,1 mill.

FCF$33,8 mill.

The company maintains a strong liquidity position, with a current ratio of 6.71, indicating that it has sufficient current assets to cover its current liabilities. However, its operating cash flow…

335810KOSDAQ—

Precision Biosensor Inc

Driftsresultat-$1,83 mrd.

FCF-$843,5 mill.

Precision Biosensor Inc has a debt-to-equity ratio of 0.54, indicating a moderate reliance on debt financing, while its current ratio of 3.27 suggests strong short-term liquidity. However, the comp…

420570KOSDAQ—

420570.Kq

Driftsresultat$2,90 mrd.

FCF$1,88 mrd.

The company maintains a strong capital structure, with a debt-to-equity ratio of 0.03, indicating minimal reliance on debt financing and a robust equity base. Its liquidity position is characterize…

6118HKEX—

Austar Lifesciences Ltd

KursHK$0.76

DriftsresultatHK$54,2 mill.

OmsetningHK$1,53 mrd.

Austar Lifesciences Ltd maintains a debt-to-equity ratio of 0.42, indicating a relatively conservative capital structure. The company's liquidity position is assessed as medium, with a current rati…

6709TPEx—

6709.Two

Driftsresultat-$70,9 mill.

FCF-$68,4 mill.

The company's capital structure is characterized by a high level of equity, with total equity amounting to TWD 152,252,000, and a relatively low level of debt, with long-term debt at TWD 3,967,000.…

6864TPEx—

6864.Two

Driftsresultat-$96,0 mill.

FCF-$89,7 mill.

The company's capital structure is characterized by a high proportion of equity, with total equity of 510,493,000 TWD and total liabilities of 9,917,000 TWD, resulting in a debt-to-equity ratio of…

6978HKEX—

Immunotech Biopharm Ltd

Driftsresultat-HK$222,9 mill.

FCF-HK$190,0 mill.

Immunotech Biopharm Ltd has a negative equity position of CNY -13.93 million, indicating a significant financial challenge, and a debt-to-equity ratio of -31.61, which suggests that the company is…

9686HKEX—

Xikang Cloud Hospital Holdings Inc

KursHK$1.01

BørsverdiHK$850,3 mill.

Xikang Cloud Hospital Holdings Inc has a market capitalization of 791.36 million CNY, with a market price of 0.94 CNY per share. The company's capital structure is currently undiluted, as the numbe…

ALTHEREuronext Paris—

Theraclion

Driftsresultat-€6,4 mill.

FCF-€5,3 mill.

Alther's capital structure is marked by a negative total equity of EUR -2,588,000 and a debt-to-equity ratio of -1.91, indicating a significant reliance on debt financing. The company's liquidity p…

CANDNSE (India)—

Cand.Ns

Driftsresultat$359,6 mill.

FCF-$114,4 mill.

CAND.NS has a debt-to-equity ratio of 0.39, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position is assessed as medium…

CLCS.PKOTC—

Clcs.Pk

Driftsresultat-$3,8 mill.

The company's capital structure is highly leveraged, with total liabilities of $18.82 million and total equity of -$18.54 million, resulting in a debt-to-equity ratio of -0.54. Liquidity is critica…